Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type and Mechanisms of Residual Asthma Exacerbations in Patients Treated With Mepolizumab

NCT04578171 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT04578171
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04578171 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type and Mechanisms of Residual Asthma Exacerbations in Patients Treated With Mepolizumab
Lead sponsor
Laval University
Phase
Observational
Overall status
Recruiting
Start date
July 6, 2021
Completion date
January 31, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma